File photo of Astana rider Armstrong of the U.S. preparing to start the individual time trial in the first stage of the 96th Tour de France cycling race in Monaco

 
File photo of Astana rider Armstrong of the U.S. preparing to start the individual time trial in the first stage of the 96th Tour de France cycling race in Monaco
Astana rider Lance Armstrong of the U.S. prepares to start the individual time trial in the first stage of the 96th Tour de France cycling race in Monaco in this July 4, 2009 file photo. Armstrong, the disgraced American cyclist at the center of the biggest doping scandal in the sport's history, may admit he used performance-enhancing drugs during his career, the New York Times reported in editions on January 5, 2013, citing "several people with direct knowledge of the situation." The newspaper said Armstrong, 41, has told associates and anti-doping officials he may make the admission in hopes of persuading anti-doping officials to allow him to resume competition in athletic events that adhere to the World Anti-Doping Code, under which Armstrong is currently subject to a lifetime ban. REUTERS/Jean-Paul Pelissier/Files